Literature DB >> 20118567

Calcium channel blockers differentially modulate cytokine production by peripheral blood mononuclear cells.

Akira Matsumori1, Ryosuke Nishio, Yoshisuke Nose.   

Abstract

BACKGROUND: Calcium channel blockers (CCB) are known to modulate immune reactions, so the present study was performed to examine the effects of various CCBs that have shown different effects on transcription factors and on the production of pro-inflammatory cytokines by human peripheral blood mononuclear cells (PBMC). METHODS AND
RESULTS: PBMC from healthy volunteers were isolated by Ficoll-paque density centrifugation. To study the effect of CCBs, the PBMC were stimulated with lipopolysaccharide or concanavalin A. After 24 h of incubation, the supernatants were harvested and the interleukin (IL)-1alpha, -1beta, and -6, tumor necrosis factor (TNF)-alpha, and interferon (IFN)-gamma levels were determined by specific enzyme-linked immunosorbent assay. The production of IL-1alpha and -1beta stimulated with lipopolysaccharide was significantly increased in the presence of amlodipine. In contrast, nifedipine and verapamil suppressed the production of IL-1beta, TNF-alpha, and IFN-gamma. Amlodipine and diltiazem significantly increased production of IL-1alpha stimulated with concanavalin A. Nifedipine inhibited production of IL-1alpha, IL-6, and IFN-gamma. Verapamil suppressed production of IFN-gamma.
CONCLUSIONS: Differential modulation of cytokine production was seen with various CCBs, and the suppressive effect of nifedipine was most prominent.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20118567     DOI: 10.1253/circj.cj-09-0467

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  23 in total

1.  Usefulness of targeting lymphocyte Kv1.3-channels in the treatment of respiratory diseases.

Authors:  Itsuro Kazama; Tsutomu Tamada; Masahiro Tachi
Journal:  Inflamm Res       Date:  2015-07-24       Impact factor: 4.575

2.  Combination of nifedipine and subtherapeutic dose of cyclosporin additively suppresses mononuclear cells activation of patients with rheumatoid arthritis and normal individuals via Ca(2+) -calcineurin-nuclear factor of activated T cells pathway.

Authors:  N-S Lai; C-L Yu; W-Y Yin; H-C Yu; H-B Huang; C-H Tung; M-C Lu
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

Review 3.  Physiological significance of delayed rectifier K(+) channels (Kv1.3) expressed in T lymphocytes and their pathological significance in chronic kidney disease.

Authors:  Itsuro Kazama
Journal:  J Physiol Sci       Date:  2014-08-06       Impact factor: 2.781

4.  Verapamil results in increased blood levels of oncolytic adenovirus in treatment of patients with advanced cancer.

Authors:  Anniina Koski; Mari Raki; Petri Nokisalmi; Ilkka Liikanen; Lotta Kangasniemi; Timo Joensuu; Anna Kanerva; Sari Pesonen; Ramon Alemany; Akseli Hemminki
Journal:  Mol Ther       Date:  2011-11-01       Impact factor: 11.454

Review 5.  Clinical roles of calcium channel blockers in ischemic heart diseases.

Authors:  Daisuke Sueta; Noriaki Tabata; Seiji Hokimoto
Journal:  Hypertens Res       Date:  2017-01-26       Impact factor: 3.872

6.  Lessons learned from experimental myocarditis.

Authors:  A Matsumori
Journal:  Herz       Date:  2012-12       Impact factor: 1.443

7.  Nifedipine attenuation of abdominal aortic aneurysm in hypertensive and non-hypertensive mice: Mechanisms and implications.

Authors:  Xiao Niu Miao; Kin Lung Siu; Hua Cai
Journal:  J Mol Cell Cardiol       Date:  2015-08-04       Impact factor: 5.000

8.  Acid-sensing ion channel 3 deficiency increases inflammation but decreases pain behavior in murine arthritis.

Authors:  Kathleen A Sluka; Lynn A Rasmussen; Meghan M Edgar; James M O'Donnell; Roxanne Y Walder; Sandra J Kolker; David L Boyle; Gary S Firestein
Journal:  Arthritis Rheum       Date:  2013-05

9.  Effect of nifedipine, a calcium channel blocker, on the generation of nitric oxide and interleukin-1β by murine macrophages activated by lipopolysaccharide from Prevotella intermedia.

Authors:  So-Hui Choe; Eun-Young Choi; Jin-Yi Hyeon; Bo Ram Keum; In Soon Choi; Sung-Jo Kim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-08-11       Impact factor: 3.000

10.  Repositioning Azelnidipine as a Dual Inhibitor Targeting CD47/SIRPα and TIGIT/PVR Pathways for Cancer Immuno-Therapy.

Authors:  Xiuman Zhou; Ling Jiao; Yuzhen Qian; Qingyu Dong; Yixuan Sun; Wei V Zheng; Wenshan Zhao; Wenjie Zhai; Lu Qiu; Yahong Wu; Hongfei Wang; Yanfeng Gao; Junhui Chen
Journal:  Biomolecules       Date:  2021-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.